Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.
How did SHNXY's recent EPS compare to expectations?
The most recent EPS for Shandong Xinhua Pharmaceutical Company Limited is $, expectations of $0.11.
How did Shandong Xinhua Pharmaceutical Company Limited SHNXY's revenue perform in the last quarter?
Shandong Xinhua Pharmaceutical Company Limited revenue for the last quarter is $
What is the revenue estimate for Shandong Xinhua Pharmaceutical Company Limited?
According to of Wall street analyst, the revenue estimate of Shandong Xinhua Pharmaceutical Company Limited range from $ to $
What's the earning quality score for Shandong Xinhua Pharmaceutical Company Limited?
Shandong Xinhua Pharmaceutical Company Limited has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Shandong Xinhua Pharmaceutical Company Limited report earnings?
Shandong Xinhua Pharmaceutical Company Limited next earnings report is expected in 2026-01-23
What are Shandong Xinhua Pharmaceutical Company Limited's expected earnings?
Shandong Xinhua Pharmaceutical Company Limited expected earnings is $, according to wall-street analysts.
Did Shandong Xinhua Pharmaceutical Company Limited beat earnings expectations?
Shandong Xinhua Pharmaceutical Company Limited recent earnings of $ expectations.